Biotech Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases May 2, 2025
Biotech Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine May 1, 2025
Biotech Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies April 30, 2025
Biotech Genocury Biotech Annouces Groundbreaking Advance in Relapsed/Refractory DLBCL Through Pioneering In Vivo CD19 CAR-T Therapy April 30, 2025
Biotech Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025 April 30, 2025
Biotech Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion April 29, 2025
Biotech Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application April 29, 2025
Biotech Comac Medical Announces New Leadership Appointments and International Expansion April 28, 2025